Synthetic Biology and the “Bioeconomy”: Feeding Fuel to the Fire of Landgrabs and
Biodiversity Loss
By Eric Hoffman and Jeff Conant,
Global Forest Coalition
| 02. 14. 2013
[For footnotes, see here]
The industrial revolution replaced wood for fossil fuels as the driver of the engine of progress, leaving living plants to take a back seat in energy production. Now, with the advent of a set of technologies known as synthetic biology, industry groups and the US Department of Energy are celebrating the advent of a new “bioeconomy” – an energy and materials economy in which products and processes previously derived from petroleum will be produced through the exploitation of biomass and biotechnology. By employing the rapidly expanding techniques of synthetic biology, the new industrialists want to turn microbes into “living chemical factories” engineered to produce substances they would not produce naturally, such as biofuels, bio-plastics, industrial chemicals and oils, and even medicines.
However, early indications show that such an approach likely harbors all of the ill-effects of the fossil fuel economy – simply swapping out black carbon for green – combined with the assault on biodiversity brought on by biotechnologies such as genetic engineering of crops. Humans have already caused a state-shift in the global ecosystem...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...